Diabetes Mellitus, Type 2 Clinical Trial
Official title:
Mindfulness-based Cognitive Therapy (MBCT) for Type II Diabetes Mellitus (DM) Patients With High Diabetes Distress and Suboptimal DM Control: a Pilot Qusai-experimental Study
Verified date | January 2019 |
Source | Chinese University of Hong Kong |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Background: Diabetes-related distress (DRD) is very common among people with type II diabetes
mellitus (DM). DRD led to poorer DM control and may led to adverse prognosis. Yet, there is
no widely accepted or recommended DRD treatment.
Mindfulness was shown to relieve psychological distress in various physical and mental
conditions.
Aim: as a pilot project, we aim to determine if mindfulness-based cognitive therapy (MBCT),
which is one of the widely used mindfulness program, is feasible and acceptable and may
improve DRD in our Chinese population.
Method: 20 Chinese participants with suboptimally controlled DM and high DRD will be
recruited to a 8- week MBCT group. Pre-group and post-group (immediate and 2-month
post-group) data including DRD score, quality-of life measures will be compared.
Status | Completed |
Enrollment | 20 |
Est. completion date | November 30, 2018 |
Est. primary completion date | November 30, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - received a clinical diagnosis of type II DM - aged >=18 - can provide valid consent - can speak Cantonese - can read and write simple Chinese - HbA1c >7% - have CDDS score >=3 Exclusion Criteria: - diagnosed active mental illness - have severe hearing loss - non-Chinese - have active suicidal ideation as screened by Q9 of PHQ-9 - unwilling to join at least 6 out of 8 session of MBCT - received mindfulness training in the past year or having regular mindfulness practice - received psychotherapy last year - severe physical illness limiting them from coming repeatedly to the group |
Country | Name | City | State |
---|---|---|---|
Hong Kong | Pok Oi Hopsital | Hong Kong |
Lead Sponsor | Collaborator |
---|---|
Chinese University of Hong Kong |
Hong Kong,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Rate of recruitment | As a pilot study, we like to determine if it is feasible to recruit the target patients and measure the relevant outcomes. The number of patient approached and the number of patient recruited will be recorded | From recruitment (1 April) till 20 patients are recruited (within 1 month) | |
Primary | Dropout rate | The proportion of patients attending at least 6 out of 8 classes | Week 1 (start of MBCT, intervention) till week 8 | |
Secondary | Chinese Version of Diabetes Distress Scale (CDDS-15) | A scale to diagnose and monitor Diabetes Related Distress. The scale ranged from score 0 to 6. The higher the score, the higher the distress. | At pre-group (week1), immediate post-group (week8) and 2 months post-group (week16) | |
Secondary | 9-item patient Health Questionnaire (PHQ-9) | A scale of depression score. Higher scores signifies more severe depression. Possible score ranged from 0-27 | At pre-group (week1), immediate post-group (week8) and 2 month post-group (week16) | |
Secondary | The Audit of Diabetes-Dependent Quality of Life (ADDQOL) | A measure of Diabetes specific quality of life. The possible score for each domain is from -9(most negative impact of diabetes) to +3 (most positive impact of diabetes). Domains include leisure work, journey, holiday, physical, family life, friendships and social life, personal relationship, sex life, physical appearance, self-confidence, motivation, reactions of other people, feelings about future, financial situation, living conditions, depend on others, freedom to eat, and freedom to drink. The total score is the weighted average of all the domain, so the total score also ranged from -9 to +3. | At pre-group (week1), immediate post-group (week8) and 2 month post-group (week16) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |